SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (6878)4/12/1998 10:13:00 PM
From: BigKNY3  Read Replies (1) | Respond to of 23519
 
VLAD << Perhaps then, the timing of the advertising ie February through March was planned so that the May sales impact on MUSE would not be as severe than if no advertising occured. What do you think?>>

VLAD: I believe the ad campaign was more directed to the investment community than the medical community. In either case, it was unsuccessful. Stopping a failing campaign makes sense and saves $.

I really don't understand how a Direct to Consumer campaign has a two month delayed effect. Patient sees the ad, patient makes an appointment, patient gets Rx. This process should not take more than a week.

Hey, I hate sounding so negative. But, VVUS marketing strategies and explanations are hard to figure out.

I believe that there is a way to successfully market MUSE in the current expanding market. However, I don't think the current management has the ability or expertise to do it. Accordingly, I am hesitate to take a long position again in VVUS. And finally, I would like to repeat...I have never shorted a stock and don't intend to!

Good investing!

BigKNY3